Astria Therapeutics is a Biotech company based in Boston. It has raised $700M in total funding. Latest round: Growth.
Astria Therapeutics funding overview
Astria Therapeutics is a Biotech company based in Boston. Astria Therapeutics has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2026. The round record for Astria Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include BioCryst, HHS, Perceptive Advisors. 3 distinct backers are named across the disclosed rounds.
Astria Therapeutics at a glance
Total raised
$700M
Latest round
Growth
Latest round date
January 2026
Industry
Biotech
Headquarters
Boston
Notable investors
BioCryst, HHS, Perceptive Advisors
Frequently asked about Astria Therapeutics funding
How much has Astria Therapeutics raised?
Astria Therapeutics has raised $700M in total disclosed funding across the rounds on record.
Who has invested in Astria Therapeutics?
BioCryst, HHS, Perceptive Advisors are named among the investors backing Astria Therapeutics.
What was the latest Astria Therapeutics funding round?
The most recent disclosed round is a Growth, announced in January 2026.
Where is Astria Therapeutics based?
Astria Therapeutics is based in Boston.
What sector does Astria Therapeutics operate in?
Astria Therapeutics is tracked under Biotech from Boston, with $700M in disclosed funding.
When did Astria Therapeutics last raise?
The last disclosed Astria Therapeutics round closed in January 2026 at Growth.
Round data for Astria Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boston and backer lists below.
